MARKET

SCLX

SCLX

Scilex Holding Co
NASDAQ
6.69
-0.26
-3.74%
After Hours: 6.69 0 0.00% 19:34 08/10 EDT
OPEN
6.95
PREV CLOSE
6.95
HIGH
7.05
LOW
6.69
VOLUME
15.24K
TURNOVER
--
52 WEEK HIGH
10.43
52 WEEK LOW
6.25
MARKET CAP
56.81M
P/E (TTM)
-0.1698
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at SCLX last week (0803-0807)?
Weekly Report · 16h ago
Weekly Report: what happened at SCLX last week (0727-0731)?
Weekly Report · 08/03 09:42
Weekly Report: what happened at SCLX last week (0720-0724)?
Weekly Report · 07/27 09:44
Scilex Announces Strategic Sale of Vivasor Preferred Shares
TipRanks · 07/22 21:54
Weekly Report: what happened at SCLX last week (0713-0717)?
Weekly Report · 07/20 09:42
Weekly Report: what happened at SCLX last week (0706-0710)?
Weekly Report · 07/13 09:44
Scilex Portfolio Company Semnur Pharmaceuticals Receives $100M Investment From iHolding In 10M Newly Issued Shares At $10 Per Share
Benzinga · 07/07 10:05
What's Going on With Scilex Holding Stock Monday?
Benzinga · 07/06 13:02
More
About SCLX
Scilex Holding Company is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company’s commercial products include ZTlidoO (lidocaine topical system) 1.8% for the relief of neuropathic pain associated with postherpetic neuralgia (PHN); ELYXYB, a ready-to-use oral solution for the acute treatment of migraine, with or without aura, in adults; and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. In addition, it focuses on product candidates, including SP-102 (10 mg, dexamethasone sodium phosphate viscous gel) (SEMDEXAO), an epidural injections formulation to treat lumbosacral radicular pain, or sciatica; SP-103 (lidocaine topical system) 5.4%, a ZTlido formulation, for the treatment of acute pain; and SP-104 (4.5 mg, low-dose naltrexone hydrochloride delayed-release capsules) (SP-104) for fibromyalgia treatment.

Webull offers Scilex Holding Co stock information, including NASDAQ: SCLX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SCLX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SCLX stock methods without spending real money on the virtual paper trading platform.